This site is intended for healthcare professionals only
LoginRegister
Sanofi gets approval for 2 rare hematologic diseases medicines in ChinaSanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color
Bayer Finerenone approved in Japan for chronic heart failureSimultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in...
Banned drug seized in KarimnagarBanned medicated soap found in Karimnagar medical shop raid
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationCDSCO Panel Approves Bayer's Real-World Use Study for Heart Failure Drug Vericiguat
AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITATCDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor)
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi launches 2025 Global Employee Stock Purchase Plan
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor
Lupin secures SBTi validation for emission reduction targetsLupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER
Eye condition NAION is a very rare side effect of semaglutide: EMA safety committeeEMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy
WockhardtWockhardt seeks DCGI nod for Zaynich
Reckitt names Ravi B as Director Corporate Communications and Corporate Affairs ( South Asia, MENARP and Africa)Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia,...
Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority NodSuspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad
X